Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Pteryxin

Copy Product Info
🥰Excellent
Catalog No. T5S1408Cas No. 13161-75-6
Alias (+)-Pteryxin

(+)-Pteryxin ((+)-Pteryxin) has muscle-relaxant props. (+)-Pteryxin shows hepatoprotective and nitric oxide prodn. inhibitory activity.

Pteryxin

Pteryxin

Copy Product Info
🥰Excellent
Purity: 99.91%
Catalog No. T5S1408Alias (+)-PteryxinCas No. 13161-75-6
(+)-Pteryxin ((+)-Pteryxin) has muscle-relaxant props. (+)-Pteryxin shows hepatoprotective and nitric oxide prodn. inhibitory activity.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$34In StockIn Stock
5 mg$60In StockIn Stock
10 mg$98In StockIn Stock
25 mg$162In StockIn Stock
50 mg$238In StockIn Stock
100 mg$357In StockIn Stock
1 mL x 10 mM (in DMSO)$67In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.91%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Pteryxin AI Summary
Pteryxin exhibits diverse bioactivity across multiple assays. It acts as an inhibitor of mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1) with a potency of 56234.1 nM and inhibits the TGF-b pathway with a potency of 7079.5 nM. Additionally, it induces DNA re-replication in MCF 10a normal breast cells at 5804.8 nM and in SW480 colon adenocarcinoma cells at 5.8 nM. It targets human tyrosyl-DNA phosphodiesterase 1 (TDP1) with potencies of 29092.9 nM in the absence of CPT and 18356.4 nM in the presence of CPT. Furthermore, Pteryxin demonstrates activity as a PTHR inhibitor with a potency of 112201.8 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
(+)-Pteryxin ((+)-Pteryxin) has muscle-relaxant props. (+)-Pteryxin shows hepatoprotective and nitric oxide prodn. inhibitory activity.
Synonyms(+)-Pteryxin
Chemical Properties
Molecular Weight386.40
FormulaC21H22O7
Cas No.13161-75-6
SmilesC\C=C(\C)C(=O)O[C@H]1[C@@H](OC(C)=O)C(C)(C)Oc2ccc3ccc(=O)oc3c12
Relative Density.1.28g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50.00 mg/mL (129.40 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2.00 mg/mL (5.18 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5880 mL12.9400 mL25.8799 mL129.3996 mL
5 mM0.5176 mL2.5880 mL5.1760 mL25.8799 mL
10 mM0.2588 mL1.2940 mL2.5880 mL12.9400 mL
20 mM0.1294 mL0.6470 mL1.2940 mL6.4700 mL
50 mM0.0518 mL0.2588 mL0.5176 mL2.5880 mL
100 mM0.0259 mL0.1294 mL0.2588 mL1.2940 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Pteryxin | purchase Pteryxin | Pteryxin cost | order Pteryxin | Pteryxin chemical structure | Pteryxin formula | Pteryxin molecular weight